Prognostic role of serum interleukin-6 levels in polytrauma patients: a comprehensive narrative review
Open Access
- 31 March 2026
- journal article
- Published by The Korean Society of Traumatology in Journal of Trauma and Injury
- Vol. 39 (1) , 4-13
Abstract
Polytrauma triggers a complex systemic inflammatory response, and early identification of high-risk patients is essential for guiding timely interventions and improving outcomes. Interleukin-6 (IL-6), a rapidly induced proinflammatory cytokine, has emerged as a potential biomarker for prognosis in the trauma setting. This narrative review summarizes current evidence on the prognostic role of IL-6 in polytrauma patients, addressing its biological functions, kinetics after injury, and associations with clinical outcomes such as acute respiratory distress syndrome, multiple organ dysfunction syndrome, intensive care unit admission, and mortality. IL-6 levels have been shown to correlate with injury severity scores and to predict complications more reliably than many other inflammatory markers, largely due to its early elevation and sustained presence in circulation. Furthermore, IL-6 measurement may inform surgical decision-making, particularly in selecting candidates for damage control strategies versus definitive care. Compared to other cytokines and acute-phase reactants, IL-6 demonstrates superior temporal responsiveness and prognostic accuracy in the early postinjury phase. Despite variability in measurement methods and the influence of external confounding factors, IL-6 holds significant promise as a clinical tool for early triage, risk stratification, and potentially therapeutic targeting in trauma care. Standardized protocols and larger multicenter studies are needed to facilitate broader adoption and integration of IL-6 into clinical algorithms.Keywords
This publication has 27 references indexed in Scilit:
- Tocilizumab, an IL6-receptor antibody, proved effective as adjuvant therapy for cytokine storm induced by severe infection in patients with hematologic malignancyAnnals of Hematology, 2023
- Using IL-6 concentrations in the first 24 h following trauma to predict immunological complications and mortality in trauma patients: a meta-analysisEuropean Journal of Trauma and Emergency Surgery, 2017
- Intestinal Permeability and Cytokine Inflammatory Response in Multiply Injured PatientsJournal of Interferon & Cytokine Research, 2006
- The effects of laparascopic cholecystectomy operation on C-reactive protein, hormones, and cytokinesJournal of Endocrinological Investigation, 2004
- Comparison of surgical stress between laparoscopic and open colonic resectionsSurgical Endoscopy, 2003
- High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130Clinical and Experimental Immunology, 2003
- Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulationEuropean Journal of Cardio-Thoracic Surgery, 2000
- Is Interleukin 6 an Early Marker of Injury Severity Following Major Trauma in Humans?Archives of Surgery, 2000
- The acute phase response: General aspectsBailliere's Clinical Rheumatology, 1994
- C‐reactive protein levels as a direct indicator of interleukin‐6 levels in humans in vivoArthritis & Rheumatism, 1992